Bristol-Myers Squibb recalls

Bristol-Myers Squibb has 5 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 29 Oct 2025. 1 is still ongoing. 1 was reported in the last 12 months. The most frequent reason is labeling errors.

Total recalls5since 2012

Last 12 months1reported

Class I240% of total

Ongoing1latest 29 Oct 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 1Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 2 40%Class II 3 60%Class III 0 0%

Why bristol-myers squibb is recalled

Product types

Injectable & IV Drugs240%
Diabetes Medication240%

By year

2025120%
2017120%
2012360%

Ongoing bristol-myers squibb recalls

1 active

Reported	Class	Recall	Company	Reason	Where
29 Oct 2025Drug	CLASS II	Opdualag (nivolumab and relatlimab-rmbw) injection recalledOpdualag	Bristol-Myers Squibb	Sterility	Nationwide

All bristol-myers squibb recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
29 Oct 2025Drug	CLASS II	Opdualag (nivolumab and relatlimab-rmbw) injection recalledOpdualag	Bristol-Myers Squibb	Sterility	Nationwide
19 Jul 2017Drug	CLASS I	EliquisTablets 5mg recalled by Bristol-myers Squibb	Bristol-myers Squibb	Packaging Defects	Nationwide
31 Oct 2012Drug	CLASS I	BiCNU (Carmustine for injection) 100 mg and Diluent recalled	Bristol-myers Squibb	Potency & Assay	Nationwide
31 Oct 2012Drug	CLASS II	Kombiglyze XR (saxagliptin and metformin HCl recalled	Bristol-myers Squibb	Labeling Errors	Nationwide
31 Oct 2012Drug	CLASS II	Kombiglyze XR (saxagliptin and metformin HCl recalled	Bristol-myers Squibb	Labeling Errors	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.